Getinge
Company Snapshot
Founded: 1904
Entity Type: Public
Employees: 11,791
Region: Americas
Revenue: $3,291.7 Millions
Revenue Year: 2024
Headquarter: Goteborg, Sweden
Corporate Address: Lindholmspiren 7A P.O. Box 8861 SE-417 56 Goteborg Sweden Tel: +46-10-335-0000 Web: www.getinge.com
Company Overview
Getinge operates in three business segments: acute care therapies, life science, and surgical workflows. Life science offers products in areas of bioreactors, sterilizers, washer-disinfectors, isolators, sterile transfer, and other disposable products and systems. The life science segment offers products and services to clients for pharma products production and medical research. The company’s products are available in more than 135 countries. In 2020, Gentinge completed the acquisition of Applikon Biotechnology, which boosted Gentinge’s portfolio in bioprocessing technologies for vaccines, antibodies, and enzymes.
Financial Highlights (FY 2024)
Net Revenue: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Acute Care Therapies : This segment offers solutions for life support in acute health conditions such as cardiac, pulmonary, and vascular therapies.
- Life Science : This segment provides a broad range of equipment, technical expertise, and consultation to safeguard contamination in biopharmaceutical production, biomedical research, medical device manufacturing, and laboratory applications.
- Surgical Workflows : This segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables, and other high-quality hardware.
Applications/End User Industries
- Pharmaceutical
- Biopharmaceutical
- Healthcare
- Biomedical Research
- Lifescience
- Surgeries
- Cardiac Therapies
- Medical Device
- Pulmonary Therapies
- Laboratory Applications
BCC Research Beacon 